Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Pharmaceutical Specialties, Inc.
FDA Inspection
•Pharmaceutical Specialties, Inc.•May 3, 2019

Pharmaceutical Specialties, Inc. – FDA Inspection, May 3, 2019

Record Details

This FDA Inspection record concerns Pharmaceutical Specialties, Inc., with an inspection on May 3, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
Pharmaceutical Specialties, Inc.
Inspection Date
May 3, 2019
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Scott A. Golladay
View Company Profile

ID · 480a4535-0bb5-4262-841f-4eff1aa484d6

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1091169
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued

FDA Citations

3
  1. 21 CFR 211.165(a)Testing and release for distribution
  2. 21 CFR 211.100(a)Absence of Written Procedures
  3. 21 CFR 211.67(b)Written procedures not established/followed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Pharmaceutical Specialties, Inc.

3
DateClassificationOfficeProject area
August 15, 2025VAIMinneapolis District OfficeDrug Quality Assurance
February 26, 2014NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 20, 2009NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
Other documents for Pharmaceutical Specialties, Inc.
  • FDA Inspection 1274911 - 2025-08-15
  • FDA Inspection 867840 - 2014-02-26
  • FDA Inspection 564154 - 2009-02-20

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Pharmaceutical Specialties, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.